SCHEMBL8856834

SCHEMBL8856834

COc1cccc(C(=O)N(N)C2(O)C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
POLB P06746 1/20 0.44
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
MCL1 Q07820 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
ALDH1A1 P00352 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPK1 P28482 2/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
HSD17B2 P37059 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8856578 0.93 CA1 (0.52) PARP1CES2CES1NPC1RAB9A
SCHEMBL8856719 0.86 CA1 (0.54) PARP1CES2CES1NPC1RAB9A
SCHEMBL8856483 0.85 NPC1 (0.50) PARP1CES2CES1NPC1RAB9A
SCHEMBL8856498 0.83 HPGD (0.47) PARP1KMT2AMEN1MAPTTDP1
SCHEMBL8856703 0.82 HCRTR1 (0.46) CES2CES1NPC1RAB9AKMT2A
SCHEMBL8856924 0.81 PARP1 (0.44) PARP1KMT2AMEN1MAPTPOLB
SCHEMBL8856540 0.80 MAPT (0.47) PARP1NPC1RAB9AKMT2AMEN1
SCHEMBL8856566 0.80 CYP1A2 (0.50) RAB9AKMT2AMEN1MAPTPOLB
SCHEMBL8856819 0.77 CA1 (0.55) NPC1MAPTPOLBALDH1A1GAA
SCHEMBL8856468 0.76 RAB9A (0.65) CES2CES1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5648381-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1997-07-15 US disclosed
EP-0566446-B1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566446-A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020046-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR PREPARATION OF SAME AND THEIR USE AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed